Sanofi

News and Events

Press Releases


February 12, 2026
Press Release: Belén Garijo to become Chief Executive Officer of Sanofi

February 10, 2026
Press Release: Sanofi completes the acquisition of Dynavax

February 9, 2026
Press Release: Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia

Upcoming Events

23Apr

2026

First Quarter 2026

First quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on April 23, 2026. The presentation will be followed by a Q&A session.

Quarterly results


30Jul

2026

Second Quarter 2026

Second quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation will be followed by a Q&A session.

Quarterly results


30Oct

2026

Third Quarter 2026

Third quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on October 30, 2026. The presentation will be followed by a Q&A session.

Quarterly results


Past Events

29Jan

2026

Fourth Quarter & Full Year 2025 Results

Fourth quarter and full year 2025 results were reviewed by management during a live audio webcast with the financial community on January 29, 2026. The presentation was followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EDT)

Quarterly results

Discover more

24Oct

2025

Third Quarter 2025

Third quarter 2025 results were reviewed by management during a live audio webcast with the financial community on October 24, 2025. The presentation was followed by a Q&A session.

Quarterly results

Discover more

31Jul

2025

Second Quarter 2025

Second quarter 2025 results were reviewed by management during a live audio webcast with the financial community on July 31, 2025. The presentation was followed by a Q&A session.

Quarterly results

Discover more